Hepatitis D

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2026-03-31
EMA Authorised: Hepcludex (bulevirtide acetate) — Gilead Sciences Ireland UC
EMA authorised Hepcludex (bulevirtide) by Gilead Sciences Ireland UC for chronic hepatitis D.